Go Pro
→ A new kind of civil war is coming after election day? (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$5.30
+1.7%		$4.61
$3.28
▼
$6.18
$688.91M1.18910,894 shs2.09 million shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.02
+1.4%		$15.78
$7.61
▼
$17.20
$862.05M1.89484,260 shs856,796 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.77
+5.5%		$0.75
$0.63
▼
$1.72
$302.21M1.371.60 million shs2.69 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$126.54
-0.5%		$112.62
$63.48
▼
$132.70
$708.11M0.97129,287 shs136,667 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
0.00%+14.97%+13.73%+40.58%+35.20%
CryoPort, Inc. stock logo
CYRX
CryoPort
0.00%+9.45%+1.86%+13.39%+91.88%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+11.57%+19.11%-7.22%-42.98%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.00%+4.69%+6.20%+33.06%+94.23%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$5.30
+1.7%		$4.61
$3.28
▼
$6.18
$688.91M1.18910,894 shs2.09 million shs
CryoPort, Inc. stock logo
CYRX
CryoPort
$17.02
+1.4%		$15.78
$7.61
▼
$17.20
$862.05M1.89484,260 shs856,796 shs
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$0.77
+5.5%		$0.75
$0.63
▼
$1.72
$302.21M1.371.60 million shs2.69 million shs
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$126.54
-0.5%		$112.62
$63.48
▼
$132.70
$708.11M0.97129,287 shs136,667 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
0.00%+14.97%+13.73%+40.58%+35.20%
CryoPort, Inc. stock logo
CYRX
CryoPort
0.00%+9.45%+1.86%+13.39%+91.88%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
0.00%+11.57%+19.11%-7.22%-42.98%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.00%+4.69%+6.20%+33.06%+94.23%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.33
Hold$5.564.95% Upside
CryoPort, Inc. stock logo
CYRX
CryoPort
2.67
Moderate Buy$18.005.76% Upside
Standard BioTools Inc. stock logo
LAB
Standard BioTools
1.67
Reduce$1.3575.37% Upside
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.00
Hold$110.00-13.07% Downside

Current Analyst Ratings Breakdown

Latest LAB, CYRX, MLAB, and CTKB Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/18/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$25.00
8/17/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold (C-) ➝ Sell (D)
8/14/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$94.00 ➝ $110.00
8/11/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Hold (C-)
8/7/2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeSell (D+) ➝ Sell (D)
8/7/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$5.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Guggenheim logo
Guggenheim
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$12.00 ➝ $16.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Roth Capital logo
Roth Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$21.00
8/7/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
8/3/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
7/24/2026
CryoPort, Inc. stock logo
CYRX
CryoPort
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$17.00 ➝ $25.00
(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$201.49M3.42N/AN/A$2.67 per share1.99
CryoPort, Inc. stock logo
CYRX
CryoPort
$176.18M4.89N/AN/A$9.19 per share1.85
Standard BioTools Inc. stock logo
LAB
Standard BioTools
$85.33M3.54N/AN/A$1.10 per share0.70
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$249.13M2.84$11.77 per share10.75$33.71 per share3.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$66.54M-$0.62N/AN/AN/A-38.98%-12.40%-9.17%11/4/2026 (Estimated)
CryoPort, Inc. stock logo
CYRX
CryoPort
$78.30M-$0.90N/AN/AN/A-20.05%-7.20%-4.30%11/3/2026 (Estimated)
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$74.90M$0.223.50N/AN/A100.36%-7.57%-6.14%11/3/2026 (Estimated)
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$6.71M$0.84150.64N/AN/A1.92%22.72%9.82%11/5/2026 (Estimated)

Latest LAB, CYRX, MLAB, and CTKB Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/10/2026Q1 2027
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
N/A$2.68N/A$0.49N/A$60.14 million
8/6/2026Q2 2026
CryoPort, Inc. stock logo
CYRX
CryoPort
-$0.1933-$0.20-$0.0067-$0.20$48.18 million$48.97 million
8/5/2026Q2 2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.0933-$0.09+$0.0033-$0.09$47.31 million$48.14 million
8/5/2026Q2 2026
Standard BioTools Inc. stock logo
LAB
Standard BioTools
-$0.0128-$0.07-$0.0573-$0.07$20.80 million$20.10 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
CryoPort, Inc. stock logo
CYRX
CryoPort
N/AN/AN/AN/AN/A
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/AN/AN/AN/AN/A
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
$0.640.51%N/A76.19%N/A

Latest LAB, CYRX, MLAB, and CTKB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/6/2026
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
quarterly$0.160.5%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
4.48
3.86
CryoPort, Inc. stock logo
CYRX
CryoPort
N/A
2.08
1.98
Standard BioTools Inc. stock logo
LAB
Standard BioTools
N/A
9.10
8.80
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
0.73
1.79
1.32

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
CryoPort, Inc. stock logo
CYRX
CryoPort
92.90%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
53.74%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
90.60%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.36%
CryoPort, Inc. stock logo
CYRX
CryoPort
9.50%
Standard BioTools Inc. stock logo
LAB
Standard BioTools
26.81%
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
702129.98 million116.52 millionOptionable
CryoPort, Inc. stock logo
CYRX
CryoPort
73850.65 million45.84 millionOptionable
Standard BioTools Inc. stock logo
LAB
Standard BioTools
389392.58 million287.33 millionOptionable
Mesa Laboratories, Inc. stock logo
MLAB
Mesa Laboratories
7175.60 million5.44 millionNot Optionable

Recent News About These Companies

Engineers Gate Manager LP Acquires 10,965 Shares of Mesa Laboratories, Inc. $MLAB
September 18 at 3:12 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-engineers-gate-manager-lp-acquires-10965-shares-of-mesa-laboratories-inc-mlab-2026-09-18/
Mesa Laboratories Shareholders Back Board And Governance Decisions
September 8, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mesa-laboratories-shareholders-back-board-and-governance-decisions?utm_source=marketbeat.com&utm_medium=referral
Bank of New York Mellon Corp Buys New Stake in Mesa Laboratories, Inc. $MLAB
September 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-buys-new-stake-in-mesa-laboratories-inc-mlab-2026-09-06/
Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors
September 2, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9065149/mesa-laboratories-inc-mlab-shares-surge-41-what-gf-score-of-75-tells-investors
Mesa Laboratories (NASDAQ:MLAB) Sets New 52-Week High - Here's Why
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-mesa-laboratories-nasdaq-mlab-sets-new-52-week-high-heres-why-2026-08-31/
Globeflex Capital L P Takes Position in Mesa Laboratories, Inc. $MLAB
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-globeflex-capital-l-p-takes-position-in-mesa-laboratories-inc-mlab-2026-08-25/
Mesa Laboratories (NASDAQ:MLAB) Reaches New 12-Month High - What's Next?
August 25, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-mesa-laboratories-nasdaq-mlab-reaches-new-12-month-high-whats-next-2026-08-25/
Ranger Investment Management L.P. Makes New $17.32 Million Investment in Mesa Laboratories, Inc. $MLAB
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ranger-investment-management-lp-makes-new-1732-million-investment-in-mesa-laboratories-inc-mlab-2026-08-24/
Mesa Laboratories, Inc.
August 22, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/mlab-mesa-laboratories-inc/vitals
Mesa Laboratories (NASDAQ:MLAB) Director R Tony Tripeny Buys 900 Shares
August 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mlab-insider-buying-and-selling-2026-08-18/
Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4630401-mesa-laboratories-targets-1_5-1_75x-net-leverage-by-fiscal-2027-exit-while-resetting-gyrolab
Mesa Laboratories, Inc. (MLAB) Q1 2027 Earnings Call Transcript
August 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934313-mesa-laboratories-inc-mlab-q1-2027-earnings-call-transcript
Mesa Laboratories (MLAB) Releases Q1 2027 Earnings: Revenue Growth but EPS Declines
August 10, 2026  |  quiverquant.comQ
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
August 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/03/3337432/30771/en/mesa-labs-announces-first-quarter-financial-results-release-date-and-inaugural-earnings-conference-call.html
Mesa Laboratories declares $0.16 dividend
July 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4611740-mesa-laboratories-declares-0_16-dividend?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=news?source=MarketBeat
MESA LABS DECLARES QUARTERLY DIVIDEND
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322487/30771/en/mesa-labs-declares-quarterly-dividend.html
Insider Selling: Mesa Laboratories (NASDAQ:MLAB) CAO Sells $39,559.00 in Stock
June 24, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mlab-insider-buying-and-selling-2026-06-24/
Insider Selling: Mesa Laboratories (NASDAQ:MLAB) CAO Sells 118 Shares of Stock
June 18, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-mlab-insider-buying-and-selling-2026-06-18/
Mesa Laboratories Executives Quietly Unload Significant Stock Holdings
June 17, 2026  |  tipranks.comhttps://www.tipranks.com/news/insider-trading/mesa-laboratories-executives-quietly-unload-significant-stock-holdings-insider-trading-news?utm_source=marketbeat.com&utm_medium=referral
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer
June 15, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mesa-laboratories-promotes-lyndsey-crennen-to-chief-accounting-officer?utm_source=marketbeat.com&utm_medium=referral
Why Mesa Laboratories, Inc.’s (MLAB) Stock Is Up 5.04%
June 5, 2026  |  aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
Illuminated GitLab logo sign on a desk in a dimly lit office with a computer screen and plant.
GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
By Thomas Hughes | September 2, 2026
Laptop displaying a stock price chart on a desk, with background TVs showing financial news and a city skyline.
3 Stocks With September Catalysts Investors Shouldn’t Ignore
By Ryan Hasson | September 6, 2026
Rocket Lab logo beside a rocket launching from its pad amid smoke and flames against a dark sky.
Rocket Lab's Sell-Off Is Fading—Is It Finally Safe to Buy?
By Ryan Hasson | August 23, 2026
Composite image of a rocket launching from a tower with flames and smoke, Earth's curvature visible in the background.
3 Space Stocks: Ready for Liftoff or Burning Up on Reentry?
By Thomas Hughes | September 1, 2026
Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$5.30 +0.09 (+1.73%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$5.30 0.00 (-0.09%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

CryoPort stock logo

CryoPort NASDAQ:CYRX

$17.02 +0.24 (+1.43%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$16.84 -0.18 (-1.03%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and human reproductive medicine markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoport Express Shippers; Cryoport ELITE -80°C Gene Therapy Shipper; Cryoport ELITE Cryosphere Shipper; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; and Cryoport bioservices, such as controlled temperature storage, fulfilment, kit production, secondary packaging, labelling of therapeutic products, and GMP raw materials storage services. It also provides CRYOGENE, an unparalleled solution that offers pre-clinical temperature-controlled biological materials management services comprising specimen storage, processing, collection, and retrieval; CRYOPD, a temperature-controlled logistics solution, which include temperature-controlled packaging and transport solutions from cryogenic temperature to controlled ambient; and IntegriCell services that comprise apheresis/leukapheresis collection, Cryoshuttle transportation, cryo-process optimization and processing services. In addition, the company offers MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; MVE Biological Solutions' Vario cryogenic system, a cryogenic freezer system that supports temperatures between -20°C and -150°C; Cryoport Cryoshuttle provides clients with dedicated local transportation support; and Tec4Med. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; and incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. Cryoport, Inc. was founded in 1999 and is headquartered in Brentwood, Tennessee.

Standard BioTools stock logo

Standard BioTools NASDAQ:LAB

$0.77 +0.04 (+5.45%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.76 0.00 (-0.62%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Standard BioTools Inc., together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument. It also provides genomics, such as X9 Real-Time PCR System, a real-time PCR analytical instrument including pre-processing steps for microfluidics-based workflows using (integrated fluidic circuit) IFCs; and IFC Controllers, a controller which is designed to work with IFC formats. In addition, the company offers analytical instruments comprising Biomark HD system, a real-time PCR analytical instrument for microfluidics-based workflows using prepared IFCs. It sells its products to academic research institutions; translational research and medicine centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology, and plant and animal research companies; and contract research organizations. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in April 2022. Fluidigm Corporation was incorporated in 1999 and is headquartered in South San Francisco, California.

Mesa Laboratories stock logo

Mesa Laboratories NASDAQ:MLAB

$126.54 -0.60 (-0.47%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$126.47 -0.07 (-0.06%)
As of 09/18/2026 05:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas